HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

CDC

Minimal Risk Levels for Hazardous Substances (MRLs)

health effects  health  disease  effects  risk  toxic  body  data  adverse  levels  acute  exposure  human  screening  public  environmental  renal  ATSDR  substances  oral 

An MRL is an estimate of the daily human exposure to a hazardous substance that is likely to be without appreciable risk of adverse noncancer health effects over a specified duration of exposure. These substance-specific estimates, which are intended to serve as screening levels, are used by ATSDR health assessors and other responders to identify contaminants and potential health effects that may be of concern at hazardous waste sites.

Preview   0 Users liked this content.
NCI

Genetics of Kidney Cancer (Renal Cell Cancer) (PDQ®)–Health Professional Version

cancer  health  cell  renal  kidney  version  professional  genetics  cancer genetics  renal cell carcinoma 

Genetics of Kidney Cancer (Renal Cell) includes the hereditary cancer syndromes von Hippel-Lindau disease, hereditary leiomyomatosis and renal cell cancer, Birt-Hogg-Dubé syndrome, and hereditary papillary renal carcinoma. Get comprehensive information on these syndromes in this clinician summary.

Preview   0 Users liked this content.
NCI

Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version

cancer  treatment  cell  renal  patient  version  transitional  pelvis  ureter  transitional cell cancer of the renal pelvis and ureter 

Transitional cell cancer of the renal pelvis and ureter treatment is primarily surgery. In the case that the cancer has spread or come back, chemotherapy is sometimes used.  Learn more about the treatment for these cancers in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Renal Cell Cancer Treatment (PDQ®)–Patient Version

cancer  treatment  cell  renal  patient  version  renal cell carcinoma 

Renal cell cancer treatment options include surgery, radiation therapy, chemotherapy, biologic therapy, and targeted therapy. Learn more about the treatment of newly diagnosed and recurrent renal cell cancer in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Health Professional Version

cancer  health  treatment  cell  renal  version  professional  transitional  pelvis  ureter  transitional cell cancer of the renal pelvis and ureter 

Transitional cell cancer of the renal pelvis and ureter treatment is primarily surgery. In metastatic or recurrent disease, chemotherapy regimens for metastatic bladder cancer are often used. Get detailed treatment information for newly diagnosed and recurrent disease in this clinician summary.

Preview   0 Users liked this content.
NCI

Renal Cell Cancer Treatment (PDQ®)–Health Professional Version

cancer  health  treatment  cell  renal  version  professional  renal cell carcinoma 

Renal cell cancer treatment options include surgery, radiation therapy, arterial embolization, targeted therapy, immunotherapy, and chemotherapy. Get detailed information about the treatment of newly diagnosed and recurrent renal cell cancer in this summary for clinicians.

Preview   0 Users liked this content.
CDC

Trends in Incidence of End-Stage Renal Disease Among PersonsWith Diagnosed Diabetes - Puerto Rico, 1996-2010

disease  diabetes  among  trends  diagnosed  personswith  incidence  endstage  renal  puerto  rico 

Nilka Ríos Burrows, MPH1, Israel Hora, MS1, Desmond E Williams, MD1, Linda S Geiss, MA1 (Author affiliations at end of text).

Preview   0 Users liked this content.